Medicinal Chemists are specialized scientists focused on the design, synthesis, and development of chemical compounds that can become pharmaceutical drugs. Their work bridges the gap between chemistry and pharmacology, applying principles of organic chemistry to develop molecules that interact with biological systems in therapeutic ways. Medicinal chemists are responsible for optimizing the chemical properties of compounds to improve their effectiveness, stability, and bioavailability. Their goal is to identify molecules that can target specific biological pathways or diseases while minimizing side effects. Through techniques like structure-activity relationship (SAR) analysis, they refine drug candidates to meet the necessary criteria for preclinical and clinical testing. Medicinal chemists are also crucial in addressing emerging healthcare challenges, such as the development of drugs for antibiotic-resistant infections.
Medicinal chemists work closely with pharmacologists, toxicologists, and formulation scientists to ensure the drug candidates are suitable for development. They are involved in every step of the drug discovery process, from the initial hit identification through to lead optimization and scale-up for clinical trials. These chemists also tackle challenges like drug resistance and metabolic degradation, working to create more potent, long-lasting therapies. With the rise of personalized medicine, medicinal chemists are increasingly focused on developing drugs tailored to individual genetic profiles. Their expertise remains essential in driving forward the discovery and development of new, life-saving therapies.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary